Evidence map›Paper›PMID 28944406›Full record

ArticlePathology oncology research : POR2019

Downregulated Adhesion-Associated microRNAs as Prognostic Predictors in Childhood Osteosarcoma.

L E A Delsin, G M Roberto, P F Fedatto, E E Engel, C A Scrideli, L G Tone, M S Brassesco

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Insight into the Role of the miR-584 Family in Human Cancers.International journal of molecular sciences · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The diagnostic effect of serum miR-139-5p as an indicator in osteosarcoma.Cancer biomarkers : section A of Disease markers · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

L E A DelsinDepartment of Genetics, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
G M RobertoRegional Blood Center, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
P F FedattoDepartment of Pediatrics, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
E E EngelDepartment of Biomechanics, Medicine and Rehabilitation of the Locomotor System, University of São Paulo, São Paulo, Brazil.
C A ScrideliDepartment of Pediatrics, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
L G ToneDepartment of Pediatrics, Ribeirão Preto School of Medicine, University of São Paulo, São Paulo, Brazil.
M S BrassescoDepartment of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, São Paulo, Brazil. solbrassesco@usp.br.
Universidade de São Paulo · BR

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/03877-3Fundação de Amparo à Pesquisa do Estado de São Paulo 2014/07117-3
6 · The paper itself

Abstract

miRNAs have been identified as key regulators of almost all cellular processes, therefore, their dysregulation is involved with several diseases, including cancer. miRNAs specifically related to the metastastic cascade are called metastamiRs and can be involved with different steps of this process, including loss of adhesion. Osteosarcoma (OS) is the most common primary malignant pediatric bone tumor that often presents metastatic disease at diagnosis; therefore, a deeper study of adhesion-associated miRNAs could shed light on its pathophysiology. Online databases were used to select four miRNAs (miR-139; miR-181b; miR-584; miR-708) predicted or validated to target proteins related to adherent junctions and focal adhesion pathways, and their expression levels and possible associations with clinical features evaluated in primary OS samples. Our results showed downregulation of miR-139-5p and miR-708-5p in OS samples compared to non-neoplastic controls. Moreover, lower expression of miR-708-5p was associated with poor overall survival and higher expression of miR-181b-5p related to worst chemotherapy response (low HUVOS level). Based on these results, we selected miR-139-5p and miR-708-5p for further functional testing. Inducing the expression of miR-139-5p diminished the clonogenic capacity of the HOS cell line, while upregulation of miR-708-5p was related to a lower cellular adhesion. In summary, this work identified new signatures of microRNA dysregulation that may serve as useful prognostic markers in this aggressive pediatric bone tumor.

Indexed as

Gene Expression Regulation, NeoplasticAdherens JunctionsAdolescentAdultBiomarkers, TumorBone NeoplasmsCase-Control StudiesChildChild, PreschoolFemaleFocal AdhesionsFollow-Up StudiesHumansMaleMicroRNAsOsteosarcomaBiomarkers, TumorMicroRNAsAdhesionMetastasismicroRNAsOsteosarcoma

Identifiers

PMID28944406
OpenAlexW2756875749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.